NeuroPace, Inc. (NPCE) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Devices 行业. 公司总部位于 Mountain View, CA, 美国. 现任CEO为 Joel D. Becker.
NPCE 拥有 IPO日期为 2021-04-22, 184 名全职员工, 在 NASDAQ Global Market, 市值为 $516.79M.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
